By acquiring new accounts and expanding into NICUs managed by existing clients, Ceribell calculates it can unlock a $400 ...
The problem applies to Abbott’s Libre 3 and Libre 3 Plus sensors. The company said it has received reports of 736 severe adverse events and seven deaths.
The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback